TOP TIERMARKET NEWSWIRE
SEC Form 4 history

ALKERMES PLC (ALKS) insider trades

ALKERMES PLC (ALKS) insider trading activity (SEC Form 4). Over the trailing 90 days, ALKS insiders filed 0 purchases totalling $0 and 8 sales totalling $4.2M — net SELLING of $4.2M. Most recent filing: Sep 3, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.

Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
0
$0
Sells (90d)
8
$4.2M
Net (90d)
-$4.2M
net selling
Most recent
Sep 3, 2026

Recent transactions

FiledInsiderRoleTypeSharesPriceValue
Sep 3, 2026Gaffin David JosephEVP, CLO, Alkermes, Inc.S Sale—$48.01$98Kfiling
Sep 1, 2026Hopkinson Craig C.EVP R, D, Chief Medical OfficeS SaleOE—$46.99$423Kfiling
Aug 17, 2026Nichols Christian ToddSVP, Chief Commercial OfficerS Sale—$49.23$373Kfiling
Aug 3, 2026Snyderman Nancy Lynn MdDirS SaleOE—$50.35$2.2Mfiling
Aug 3, 2026Hopkinson Craig C.EVP R, D, Chief Medical OfficeS SaleOE—$48.58$437Kfiling
Aug 3, 2026Gaffin David JosephEVP, CLO, Alkermes, Inc.S Sale—$48.58$99Kfiling
Jul 6, 2026Gaffin David JosephEVP, CLO, Alkermes, Inc.S Sale—$54.03$110Kfiling
Jul 1, 2026Hopkinson Craig C.EVP R, D, Chief Medical OfficeS SaleOE—$51.51$464Kfiling
Jun 12, 2026Wright Christopher IDirS Sale—$45.10$90Kfiling
Jun 4, 2026Gaffin David JosephEVP, CLO, Alkermes, Inc.S Sale—$43.05$88Kfiling
Jun 1, 2026Hopkinson Craig C.EVP R, D, Chief Medical OfficeS SaleOE—$41.67$375Kfiling
May 29, 2026Parisi Samuel JosephVP, Finance (Interim PAO)S SaleOE—$42.36$687Kfiling